Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CLLS

Cellectis (CLLS)

Cellectis SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLLS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
11/09/2023	4:01PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/06/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/06/2023	4:30PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/06/2023	4:30PM	GlobeNewswire Inc.	Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023	NASDAQ:CLLS	Cellectis SA
11/02/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/02/2023	4:30PM	GlobeNewswire Inc.	Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I Trials at the American Society of Hematology (ASH) 65th Annual Meeting	NASDAQ:CLLS	Cellectis SA
11/01/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/01/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/01/2023	4:30PM	GlobeNewswire Inc.	Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023	NASDAQ:CLLS	Cellectis SA
11/01/2023	3:15PM	AllPennyStocks.com	Biotech Shares Soar After AstraZeneca Stake & Research Collaboration	NASDAQ:CLLS	Cellectis SA
11/01/2023	7:52AM	Dow Jones News	Cellectis Shares Soar Premarket on AstraZeneca Deal	NASDAQ:CLLS	Cellectis SA
11/01/2023	7:51AM	Dow Jones News	Cellectis Shares Soar Premarket on AstraZeneca Deal	NASDAQ:CLLS	Cellectis SA
11/01/2023	7:51AM	Dow Jones News	Cellectis Shares Soar Premarket on AstraZeneca Deal	NASDAQ:CLLS	Cellectis SA
11/01/2023	6:44AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
11/01/2023	4:17AM	Dow Jones News	AstraZeneca to Invest $245 Million in Deal With Cellectis	NASDAQ:CLLS	Cellectis SA
11/01/2023	3:00AM	GlobeNewswire Inc.	Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca	NASDAQ:CLLS	Cellectis SA
10/31/2023	5:10PM	Edgar (US Regulatory)	Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]	NASDAQ:CLLS	Cellectis SA
10/31/2023	5:09PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
10/31/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
10/31/2023	4:30PM	GlobeNewswire Inc.	Cellectis Presents Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting	NASDAQ:CLLS	Cellectis SA
10/24/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
10/12/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
10/12/2023	4:30PM	GlobeNewswire Inc.	Cellectis and Imagine Institute Publish A Proof-Of-Concept Study of a Gene Surgery Candidate to Treat Activated Phosphoinositide 3-Kinase Δ Syndrome Type 1 (APDS1)	NASDAQ:CLLS	Cellectis SA
09/27/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
09/27/2023	4:30PM	GlobeNewswire Inc.	Cellectis to Present Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting	NASDAQ:CLLS	Cellectis SA
09/05/2023	4:32PM	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:CLLS	Cellectis SA
08/07/2023	5:05PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CLLS	Cellectis SA
08/07/2023	4:35PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA
08/07/2023	4:30PM	GlobeNewswire Inc.	Cellectis Provides Full Report for Second Quarter 2023 Financial Results	NASDAQ:CLLS	Cellectis SA
08/07/2023	4:17PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CLLS	Cellectis SA

Showing the most relevant articles for your search:NASDAQ:CLLS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Northwest Biotherapeutics (QB)

Ethema Health (PK)

Asia Broadband (PK)

1812 Brewing (PK)

Kraig Biocraft Laborator... (QB)

Faraday Future Intellige...

Bioelectronics (PK)

Digital Brand Media and ... (PK)

Branded Legacy (PK)

Fannie Mae (QB)

Emergent Health (PK)

SMC Entertainment (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions